Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Semaglutide is considered safe for many people who meet the medical and weight-related criteria, but its not right for everyone
Over time, obese patients lose roughly 12% of their body weight on Wegovy (semaglutide) and about 18% on Zepbound (tirzepatide, which targets GLP-1 and another gut hormone, GIP.) Diana Thiara, MD, medical director of the UCSF Weight Management Program, says the results can be amazing and life-changing for people with obesity, a condition linked to a host of health risks
Prefer in-person medical care: Those who value face-to-face interactions with healthcare providers may find traditional medical settings more appropriate
Rotating between at least three sites prevents tissue buildup and ensures consistent absorption
Clinical settings often prefer this site because it is easily accessible by a healthcare provider and typically has adequate subcutaneous tissue even in leaner individuals
US$ 23.92
US$ 25.45
US$ 26.66
US$ 21.57
